HBDDE is a selective inhibitor of PKCα and PKCγ (IC50 = 43 μM and 50 μM, respectively), with higher selectivity over PKCδ, PKCβI, and PKCβII; it induces neuronal apoptosis and significantly reduces cerebellar granule cell viability by ~70% at 50 μM after 5 hours of treatment, accompanied by a marked increase in caspase-3 activity.